Pfizer Inc

The CDC voted Thursday to recommend updated versions of both the Pfizer and Moderna coronavirus vaccine boosters, paving way for a widespread rollout as early as next week.

The FDA authorized the first COVID-19 vaccination for children as young as six months on Friday. A panel of CDC advisors will vote Saturday, meaning shots for infants and preschoolers could be available as early as next week.

The FDA announced Tuesday that it has expanded eligibility for the Pfizer booster shot to include children ages 5 to 11.

U.S. stock futures fell Wednesday, one day after the Dow and S&P 500 logged four-session winning streaks and the Nasdaq saw back-to-back gains.

The FDA and CDC announced Tuesday that both agencies had expanded eligibility for a second booster shot of the Pfizer or Moderna coronavirus vaccines for all adults over the age of 50.

The CDC and FDA made the decision without consulting their committees of independent vaccine experts.

“You have people that are younger adults that have comorbidity factors, and they might need [a] sooner fourth dose to protect them,” CEO Stephane Bancel told CNBC.

Moderna also asked the FDA to authorize its vaccine for children 6- to 11-years-old, the company announced Wednesday.

AstraZeneca has taken a roughly £25 million ($33 million) stake in U.K. health start-up Huma, according to a person familiar with the matter.

These are the stocks posting the largest moves in midday trading.

U.S. stock futures bounced Tuesday after the Dow began the week by breaking a five-session winning streak.

Pfizer expects to start supplying the antiviral pills, Paxlovid, to UNICEF beginning next month and will continue to do so through the end of the year.

Officials say the new BA.2 Covid variant is about 50% to 60% more transmissible than omicron, but it does not appear to be more severe.

These are the stocks posting the largest moves in midday trading.

U.S. stock futures dropped Friday, but the S&P 500 remained on track for its best week since November 2020.

These are the stocks posting the largest moves before the bell.

Moderna CEO Stephane Bancel has sold more than 2.8 million shares since January 2020 at a total value of more than $408 million.

Pfizer asked the FDA Tuesday to authorize a second booster dose of its COVID-19 vaccine for Americans ages 65 and over.

The S&P 500 and Nasdaq are looking for back-to-back positive sessions for the first time since late February.

The Fed is expected to raise interest rates for the first time since December 2018, while Russian and Ukrainian officials suggest some progress on peace talks.